And in hypoxic tumor models, apigenin overcomes paclitaxel resistance by suppressing AKT and heat shock protein 90 (HSP90) signaling, which hinders the production of hypoxia-inducible factor-1α (HIF-1α) [63]. Here, AKT1 is linked to neoplasm.